Theracryf (TCF) Stock Chart & Stock Price History GBX 0.23 +0.00 (+1.78%) As of 08/13/2025 06:18 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsBuy This Stock Theracryf Stock Price Performance The Theracryf (TCF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 68.97%, with a year-to-date return of -57.43%. In the past month, the stock has decreased 2.97%, reflecting recent market activity. As of the latest close, Theracryf traded at GBX 0.23 with a market cap of £1.09 million and volume of 400,000 shares. Receive TCF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theracryf and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.43%1 Month Performance-2.97%3 Month Performance-8.40%Year-To-Date Performance-57.43%1 Year Performance-68.97% TCF Stock Chart for Thursday, August, 14, 2025 TCF Chart by TradingView Theracryf Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/13/2025GBX 0.22GBX 0.23+4.09%GBX 0.23GBX 0.23400,000 shs£1.09 million08/12/2025GBX 0.23GBX 0.22-4.35%GBX 0.23GBX 0.2294,195 shs£1.05 million08/11/2025GBX 0.23GBX 0.23GBX 0.25GBX 0.222.11 million shs£1.10 million08/08/2025GBX 0.23GBX 0.23GBX 0.24GBX 0.2352,867 shs£1.10 million08/07/2025GBX 0.23GBX 0.23-0.86%GBX 0.25GBX 0.23805,587 shs£1.10 million08/06/2025GBX 0.24GBX 0.23-2.52%GBX 0.24GBX 0.231.64 million shs£1.11 million08/05/2025GBX 0.26GBX 0.24-7.03%GBX 0.25GBX 0.243.60 million shs£1.14 million08/04/2025GBX 0.25GBX 0.26+2.40%GBX 0.26GBX 0.234.20 million shs£1.22 million08/01/2025GBX 0.22GBX 0.25+12.61%GBX 0.25GBX 0.2360.41 million shs£1.19 million07/31/2025GBX 0.22GBX 0.22+0.91%GBX 0.25GBX 0.225.12 million shs£1.06 million Get the Latest News and Ratings for TCF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theracryf and its competitors with MarketBeat's FREE daily newsletter. 07/30/2025GBX 0.23GBX 0.22-4.35%GBX 0.23GBX 0.2286,905 shs£1.05 million07/29/2025GBX 0.23GBX 0.23GBX 0.23GBX 0.221.84 million shs£1.10 million07/28/2025GBX 0.23GBX 0.23GBX 0.23GBX 0.232,173 shs£1.10 million07/25/2025GBX 0.22GBX 0.23+4.55%GBX 0.23GBX 0.211.30 million shs£1.10 million07/24/2025GBX 0.22GBX 0.22GBX 0.23GBX 0.221.60 million shs£1.05 million07/23/2025GBX 0.24GBX 0.22-8.33%GBX 0.24GBX 0.221.89 million shs£1.05 million07/22/2025GBX 0.26GBX 0.24-6.25%GBX 0.25GBX 0.233.31 million shs£1.15 million07/21/2025GBX 0.23GBX 0.26+11.30%GBX 0.26GBX 0.23110,333 shs£1.22 million07/18/2025GBX 0.26GBX 0.23-12.55%GBX 0.25GBX 0.231.70 million shs£1.10 million07/17/2025GBX 0.28GBX 0.26-6.07%GBX 0.27GBX 0.23639,245 shs£1.26 million07/16/2025GBX 0.23GBX 0.28+20.17%GBX 0.28GBX 0.232.98 million shs£1.34 million07/15/2025GBX 0.24GBX 0.23-1.27%GBX 0.28GBX 0.231.89 million shs£1.11 million07/14/2025GBX 0.24GBX 0.24GBX 0.28GBX 0.2377,143 shs£1.13 million Related Companies HSBA Stock Chart BNC Stock Chart BARC Stock Chart LLOY Stock Chart NWG Stock Chart RKT Stock Chart BUR Stock Chart BCG Stock Chart TRST Stock Chart BOY Stock Chart Receive TCF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theracryf and its competitors with MarketBeat's FREE daily newsletter. This page (LON:TCF) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGet This Stock NowThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theracryf Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Theracryf With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access